Logo image of CTRM

CASTOR MARITIME INC (CTRM) Stock Fundamental Analysis

NASDAQ:CTRM - Nasdaq - MHY1146L2082 - Common Stock - Currency: USD

2.59  -0.13 (-4.78%)

After market: 2.65 +0.06 (+2.32%)

Fundamental Rating

5

Taking everything into account, CTRM scores 5 out of 10 in our fundamental rating. CTRM was compared to 29 industry peers in the Marine Transportation industry. CTRM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CTRM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year CTRM was profitable.
CTRM had a positive operating cash flow in the past year.
Of the past 5 years CTRM 4 years were profitable.
Of the past 5 years CTRM 4 years had a positive operating cash flow.
CTRM Yearly Net Income VS EBIT VS OCF VS FCFCTRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M

1.2 Ratios

CTRM's Return On Assets of 12.35% is fine compared to the rest of the industry. CTRM outperforms 75.00% of its industry peers.
CTRM has a Return On Equity of 12.51%. This is comparable to the rest of the industry: CTRM outperforms 50.00% of its industry peers.
CTRM's Return On Invested Capital of 2.14% is on the low side compared to the rest of the industry. CTRM is outperformed by 67.86% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CTRM is in line with the industry average of 8.55%.
The last Return On Invested Capital (2.14%) for CTRM is well below the 3 year average (7.42%), which needs to be investigated, but indicates that CTRM had better years and this may not be a problem.
Industry RankSector Rank
ROA 12.35%
ROE 12.51%
ROIC 2.14%
ROA(3y)11.2%
ROA(5y)6.96%
ROE(3y)14.91%
ROE(5y)9.93%
ROIC(3y)7.42%
ROIC(5y)5.38%
CTRM Yearly ROA, ROE, ROICCTRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5 10 15 20 25

1.3 Margins

The Profit Margin of CTRM (90.98%) is better than 96.43% of its industry peers.
In the last couple of years the Profit Margin of CTRM has grown nicely.
CTRM's Operating Margin of 19.72% is on the low side compared to the rest of the industry. CTRM is outperformed by 60.71% of its industry peers.
CTRM's Operating Margin has declined in the last couple of years.
CTRM has a better Gross Margin (60.81%) than 67.86% of its industry peers.
In the last couple of years the Gross Margin of CTRM has declined.
Industry RankSector Rank
OM 19.72%
PM (TTM) 90.98%
GM 60.81%
OM growth 3Y64.19%
OM growth 5Y-17.96%
PM growth 3YN/A
PM growth 5Y2.11%
GM growth 3Y12.21%
GM growth 5Y-2.48%
CTRM Yearly Profit, Operating, Gross MarginsCTRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTRM is destroying value.
Compared to 1 year ago, CTRM has more shares outstanding
Compared to 5 years ago, CTRM has more shares outstanding
The debt/assets ratio for CTRM has been reduced compared to a year ago.
CTRM Yearly Shares OutstandingCTRM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
CTRM Yearly Total Debt VS Total AssetsCTRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

An Altman-Z score of 3.34 indicates that CTRM is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 3.34, CTRM belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
There is no outstanding debt for CTRM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.14
Altman-Z 3.34
ROIC/WACC0.24
WACC8.84%
CTRM Yearly LT Debt VS Equity VS FCFCTRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

A Current Ratio of 32.20 indicates that CTRM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 32.20, CTRM belongs to the top of the industry, outperforming 96.43% of the companies in the same industry.
CTRM has a Quick Ratio of 32.06. This indicates that CTRM is financially healthy and has no problem in meeting its short term obligations.
CTRM has a Quick ratio of 32.06. This is amongst the best in the industry. CTRM outperforms 96.43% of its industry peers.
Industry RankSector Rank
Current Ratio 32.2
Quick Ratio 32.06
CTRM Yearly Current Assets VS Current LiabilitesCTRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

2

3. Growth

3.1 Past

CTRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.79%.
Measured over the past years, CTRM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -51.52% on average per year.
The Revenue for CTRM has decreased by -25.38% in the past year. This is quite bad
CTRM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 85.79% yearly.
EPS 1Y (TTM)-48.79%
EPS 3YN/A
EPS 5Y-51.52%
EPS Q2Q%116.67%
Revenue 1Y (TTM)-25.38%
Revenue growth 3Y98.39%
Revenue growth 5Y85.79%
Sales Q2Q%-37.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTRM Yearly Revenue VS EstimatesCTRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 50M 100M 150M
CTRM Yearly EPS VS EstimatesCTRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 1.02, the valuation of CTRM can be described as very cheap.
Based on the Price/Earnings ratio, CTRM is valued cheaper than 96.43% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.62, CTRM is valued rather cheaply.
Industry RankSector Rank
PE 1.02
Fwd PE N/A
CTRM Price Earnings VS Forward Price EarningsCTRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

89.29% of the companies in the same industry are more expensive than CTRM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.1
EV/EBITDA -8.68
CTRM Per share dataCTRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CTRM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CASTOR MARITIME INC

NASDAQ:CTRM (2/21/2025, 8:11:16 PM)

After market: 2.65 +0.06 (+2.32%)

2.59

-0.13 (-4.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryMarine Transportation
Earnings (Last)02-13 2025-02-13
Earnings (Next)05-12 2025-05-12
Inst Owners4.13%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap25.02M
Analysts0
Price TargetN/A
Short Float %0.48%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DP3.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.02
Fwd PE N/A
P/S 0.33
P/FCF 2.1
P/OCF 0.59
P/B 0.05
P/tB 0.05
EV/EBITDA -8.68
EPS(TTM)2.54
EY98.07%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.23
FCFY47.54%
OCF(TTM)4.41
OCFY170.14%
SpS7.91
BVpS57.54
TBVpS57.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.35%
ROE 12.51%
ROCE 2.71%
ROIC 2.14%
ROICexc 3.69%
ROICexgc 3.69%
OM 19.72%
PM (TTM) 90.98%
GM 60.81%
FCFM 15.56%
ROA(3y)11.2%
ROA(5y)6.96%
ROE(3y)14.91%
ROE(5y)9.93%
ROIC(3y)7.42%
ROIC(5y)5.38%
ROICexc(3y)8.78%
ROICexc(5y)6.38%
ROICexgc(3y)8.78%
ROICexgc(5y)6.38%
ROCE(3y)9.4%
ROCE(5y)6.81%
ROICexcg growth 3Y69.38%
ROICexcg growth 5Y-30.11%
ROICexc growth 3Y69.38%
ROICexc growth 5Y-30.11%
OM growth 3Y64.19%
OM growth 5Y-17.96%
PM growth 3YN/A
PM growth 5Y2.11%
GM growth 3Y12.21%
GM growth 5Y-2.48%
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.14
Debt/EBITDA 0
Cap/Depr 192.91%
Cap/Sales 40.13%
Interest Coverage 250
Cash Conversion 137.44%
Profit Quality 17.1%
Current Ratio 32.2
Quick Ratio 32.06
Altman-Z 3.34
F-Score7
WACC8.84%
ROIC/WACC0.24
Cap/Depr(3y)888.24%
Cap/Depr(5y)1289.46%
Cap/Sales(3y)93.95%
Cap/Sales(5y)170.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.79%
EPS 3YN/A
EPS 5Y-51.52%
EPS Q2Q%116.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.38%
Revenue growth 3Y98.39%
Revenue growth 5Y85.79%
Sales Q2Q%-37.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.9%
EBIT growth 3Y225.75%
EBIT growth 5Y52.42%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-92.65%
FCF growth 3YN/A
FCF growth 5Y97.38%
OCF growth 1Y-61.13%
OCF growth 3YN/A
OCF growth 5Y97.96%